Skip to main content
SpringerLink
Log in

Behavioral Methods in Cannabinoid Research

  • Protocol
Marijuana and Cannabinoid Research

Part of the book series: Methods In Molecular Medicine™ ((MIMM,volume 123))

Summary

In the absence of any specific behavioral assay for cannabinoids or endocannabinoids, a cannabinoid-induced profile in a series of four in vivo assays in mice is most commonly used to assess a specific cannabinoid activity at the behavioral level. Thus, when a given compound produces motor depression in an open field, catalepsy on an elevated ring, analgesia on a hot plate, as well as hypothermia, cannabinoid CB1 receptor activation is assumed, although exceptions are possible. The full cannabinoid profile, however, includes for example ataxia in dogs and discrimination learning in rats. In view of (1) the addictive/reward potential of cannabis and the cannabinoids and (2) the multiple roles of the endocannabinoid physiological control system (EPCS) in behavioral functions, including memory, emotionality, and feeding, a number of behavioral techniques have been used to assess the effects of cannabinoids in these functions. In this chapter we will describe the tetrad of cannabinoid-induced effects as well as a series of behavioral assays used in the behavioral pharmacology of marijuana-cannabinoid research. Since the EPCS plays an important role in the developing organism, methods used in the assessment of physical and behavioral development will also be discussed. The techniques include the tetrad, drug discrimination, self-stimulation and self-administration, conditioned place preference/aversion, the plus-maze, chronic mild stress (CMS), ultrasonic vocalizations, cognitive behaviors, and developmental assessment in mouse (and rat) pups.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fride, E. and Shohami, E. (2002) The endocannabinoid system: function in survival of the embryo, the newborn and the neuron.. Neuroreport 13, 1833–1841.

    Article  CAS  PubMed  Google Scholar 

  2. Mechoulam, R., Hanus, L, and Fride, E. (1998) Towards cannabinoid drugs—revisited. Prog. Med. Chem. 35, 199–243.

    Article  CAS  PubMed  Google Scholar 

  3. Treit, D. and Menard, J. (1998) Animal models of anxiety and depression, in In Vivo Neuromethods (Boulton, E., Baker, G., and Bateson, A., eds.), Humana Press, Totowa, NJ.

    Google Scholar 

  4. Martin, B. R., Compton, D. R., Thomas, B. F., et al. (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40, 471–478.

    Article  CAS  PubMed  Google Scholar 

  5. Abood, M. E. and Martin, B. R. (1992) Neurobiology of marijuana abuse. Trends Pharmacol. Sci. 13, 201–206.

    Article  CAS  PubMed  Google Scholar 

  6. Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., and Martin, B. R. (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265, 218–226.

    CAS  PubMed  Google Scholar 

  7. Razdan, R. K. (1986) Structure-activity relationships in cannabinoids. Pharmacol. Rev. 38, 75–149.

    CAS  PubMed  Google Scholar 

  8. Little, P. J. and Martin, B. R. (1991) The effects of delta 9-tetrahydrocannabinol and other cannabinoids on cAMP accumulation in synaptosomes. Life Sci. 48, 1133–1141.

    Article  CAS  PubMed  Google Scholar 

  9. Adams, I. B., Compton, D. R., and Martin, B. R. (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J. Pharmacol. Exp. Ther. 284, 1209–1217.

    CAS  PubMed  Google Scholar 

  10. Adams, I. B., Ryan, W., Singer, M., Thomas, B. F., Compton, D. R., Razdan, R. K., and Martin, B. R. (1995) Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273, 1172–1181.

    CAS  PubMed  Google Scholar 

  11. Fride, E. and Mechoulam, R. (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313–314.

    Article  CAS  PubMed  Google Scholar 

  12. Little, P. J., Compton, D. R., Mechoulam, R., and Martin, B. R. (1989) Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behav. 32, 661–666.

    Article  CAS  PubMed  Google Scholar 

  13. Pertwee, R. G. (1972) The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice. Br. J. Pharmacol. 46, 753–763.

    CAS  PubMed  Google Scholar 

  14. Martin, B. R., Prescott,W. R., and Zhu, M. (1992) Quantitation of rodent catalepsy by a computer-imaging technique. Pharmacol. Biochem. Behav. 43, 381–386.

    Article  CAS  PubMed  Google Scholar 

  15. Fride, E. (1995) Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol. Brain Res. 697, 83–90.

    Article  CAS  PubMed  Google Scholar 

  16. Segal, M. (1986) Cannabinoids and analgesia, in Cannabinoids as Therapeutic Agents. (Mechoulam, R., ed..), CRC Press, Boca Raton, FL, pp. 106–120.

    Google Scholar 

  17. Tjolsen, A. and Hole, K. (1997) Animal models of analgesia., in The Pharmacology of Pain (Dickenson, L., and Bessing, J., eds.), Springer, Heidelberg, pp. 1–20.

    Google Scholar 

  18. Ankier, S. I. (1974) New hot plate tests to quantify antinociceptive and narcotic antagonist activities. Eur J Pharmacol 27, 1–4.

    Article  CAS  PubMed  Google Scholar 

  19. Balster, R. L. and Prescott, W. R. (1992) Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci. Biobehav. Rev. 16, 55–62.

    Article  CAS  PubMed  Google Scholar 

  20. Devane, W. A., Hanus, L., Breuer, A., et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946–1949.

    Article  CAS  PubMed  Google Scholar 

  21. Hanus, L., Gopher, A., Almog, S., and Mechoulam, R. (1993) Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 36, 3032–3034.

    Article  CAS  PubMed  Google Scholar 

  22. Mechoulam, R., Ben-Shabat, S., Hanus, L., et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83–90.

    Article  CAS  PubMed  Google Scholar 

  23. Hanus, L., Abu-Lafi, S., Fride, E., et al. (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA 98, 3662–3665.

    Article  CAS  PubMed  Google Scholar 

  24. Porter, A. C., Sauer, J. M., Knierman, M. D., et al. (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther. 301, 1020–1024.

    Article  CAS  PubMed  Google Scholar 

  25. Walker, J. M., Krey, J. F., Chu, C. J., and Huang, S. M.. (2002) Endocannabinoids and related fatty acid derivatives in pain modulation. Chem. Phys. Lipids 121, 159–172.

    Article  CAS  PubMed  Google Scholar 

  26. Mechoulam, R. and Fride, E. (1995) The unpaved road to the endogenous brain cannabinoid ligands, the anandamides, in Cannabinoid Receptors (Pertwee, R. G., ed), Academic Press, London, pp. 233–258.

    Google Scholar 

  27. Fride, E., Barg, J., Levy, R., Saya, D., Heldman, E., Mechoulam, R., and Vogel, Z. (1995) Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 272, 699–707.

    CAS  PubMed  Google Scholar 

  28. Mackie, K., Devane, W. A., and Hille, B. (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacoll. 44, 498–503.

    CAS  Google Scholar 

  29. Smith, P. B., Compton, D. R., Welch, S. P., Razdan, R. K., Mechoulam, R., and Martin, B. R. (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270, 219–227.

    PubMed  Google Scholar 

  30. Welch, S. P., Dunlow, L. D., Patrick, G. S., and Razdan, R.K. (1995) Characterization of anandamide-and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception. J. Pharmacol. Exp. Ther. 273, 1235–1244.

    CAS  PubMed  Google Scholar 

  31. Mallet, P. E. and Beninger, R.J. (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berl.) 140, 11–19.

    Article  CAS  Google Scholar 

  32. Sulcova, E., Mechoulam, R., and Fride, E. (1998) Biphasic effects of anandamide. Pharmaco. Biochem. Behav. 59, 347–352.

    Article  CAS  Google Scholar 

  33. Cruciani, R. A., Dvorkin, B., Morris, S. A., Crain, S. M., and Makman, M. H. (1993) Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc. Natl. Acad. Sci. USA 90,3019–3023.

    Article  CAS  PubMed  Google Scholar 

  34. Glass, M. and Felder, C. C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17, 5327–5333.

    CAS  PubMed  Google Scholar 

  35. Wiley, J. L., Huffman, J. W., Balster, R. L., and Martin, B. R. (1995) Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend. 40, 81–86.

    Article  CAS  PubMed  Google Scholar 

  36. Di Marzo, V., Melck, D., Bisogno, T., and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521–528.

    Article  PubMed  Google Scholar 

  37. Burkey, R. T. and Nation, J. R. (1997) (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure. Exp. Clin. Psychopharmacol. 5, 195–202.

    Article  CAS  PubMed  Google Scholar 

  38. Jarbe, T. U., Lamb, R. J., Makriyannis, A., Lin, S., and Goutopoulos, A. (1998) Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology (Berl.) 140, 519–522.

    Article  CAS  Google Scholar 

  39. Wiley, J. L., Golden, K. M., Ryan, W. J., Balster, R. L., Razdan, R. K., and Martin, B. R. (1997) Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Pharmacol. Biochem. Behav. 58, 1139–1143.

    Article  CAS  PubMed  Google Scholar 

  40. Gardner, E. L. (2002) Marijuana addiction and CNS reward-related events, in The Biology of Marijuana (Onaivi, E., ed.), Harwood Academic Publishers, Reading, pp. 75–109.

    Google Scholar 

  41. Gardner, E. L. and Lowinson, J. H. (1991) Marijuana’s interaction with brain reward systems: update 1991. Pharmacol. Biochem. Behav. 40, 571–580.

    Article  CAS  PubMed  Google Scholar 

  42. Markou, A. and Koob, G. (1993) Intracranial self-stimulation threshold as a measure of reward, in: Behavioral Neuroscience: A Practical Approach, Vol. 2 (Sahgal, A., ed.), IRL Press, Oxford, pp. 93–115.

    Google Scholar 

  43. Crawley, J. N., (2000) What’s Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice, Wiley-Liss, New York.

    Google Scholar 

  44. Cain, S., Lintz, R., and Koob, G.F. (1993) Intravenous drug self-administration techniques in animals, in Behavioral Neuroscience: A Practical Approach, Vol. 2 Sahgal, A., ed.), IRL Press, Oxford, pp. 93–115.

    Google Scholar 

  45. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J. F., Beslot, F., Bohme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., Vassart, G., Fratta, W., and Parmentier, M. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401–404.

    Article  CAS  PubMed  Google Scholar 

  46. Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., and Fratta, W. (1998) Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience 85, 327–330.

    Article  CAS  PubMed  Google Scholar 

  47. Braida, D., Pozzi, M., Parolaro, D., and Sala, M.. (2001) Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system, Eur. J. Pharmacol. 413, 227–234.

    Article  CAS  PubMed  Google Scholar 

  48. Tanda, G., Munzar, P., and Goldberg, S. R. (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat. Neurosci. 3, 1073–1074.

    Article  CAS  PubMed  Google Scholar 

  49. Valjent, E. and Maldonado, R. (2000). A behavioural model to reveal place preference to 9-tetrahydrocannabinol in mice. Psychopharmacology 147, 436–438.

    Article  CAS  PubMed  Google Scholar 

  50. Pellow, S., Chopin, P., File, S. E., and Briley, M. (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149–167.

    Article  CAS  PubMed  Google Scholar 

  51. Fride, E and Weinstock, M. (1988) Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity. Life Sci. 42, 1059–1065.

    Article  CAS  PubMed  Google Scholar 

  52. Onaivi, E. S., Green, M. R., and Martin, B. R. (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Ther. 253, 1002–1009.

    CAS  PubMed  Google Scholar 

  53. Giuliani, D., Ferrari, F., and Ottani, A. (2000) The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress. Pharmacol. Res. 41, 47–53.

    Article  CAS  PubMed  Google Scholar 

  54. Chakrabarti, A., Ekuta, J. E., and Onaivi, E. S. (1998) Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res. Bull. 45, 67–74.

    Article  CAS  PubMed  Google Scholar 

  55. Weidenfeld, J., Feldman, S., and Mechoulam, R. (1994) Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology 59, 110–112.

    Article  CAS  PubMed  Google Scholar 

  56. Rodriguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G. F., and Navarro, M. (1996) Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats, J Pharmacol. Exp. Ther. 276, 56–64.

    Google Scholar 

  57. Sanchez, C. (2003) Stress-induced vocalisation in adult animals. A valid model of anxiety? Eur. J. Pharmacol. 463, 133–143.

    Article  CAS  PubMed  Google Scholar 

  58. Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., and Wadleigh, R. G. (1991) Recent clinical experience with dronabinol. Pharmacol. Biochem. Behav. 40, 695–700.

    Article  CAS  PubMed  Google Scholar 

  59. Beal, J. E., Olson, R., Lefkowitz, L., Laubenstein, L., Bellman, P., Yangco, B., Morales, J. O., Murphy, R., Powderly, W., Plasse, T. F., Mosdell, K. W., and Shepard, K. V. (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J. Pain Symptom Manage. 14, 7–14.

    Article  CAS  PubMed  Google Scholar 

  60. Timpone, J. G., Wright, D. J., Li, N., Egorin, M.. J., Enama, M. E., Mayers, J., and Galeto, G. (1997). The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome. The DATRI 0004 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res. Hum. Retrovirus 13, 305–315.

    Article  CAS  Google Scholar 

  61. Mattes, R. D., Engelman, K., Shaw, L. M., and Elsohly, M. A. (1994) Cannabinoids and appetite stimulation. Pharmacol. Biochem. Behav. 49, 187–195.

    Article  CAS  PubMed  Google Scholar 

  62. Foltin, R. W., Brady, J. V., and Fischman, M. W. (1986) Behavioral analysis of marijuana effects on food intake in humans. Pharmacol. Biochem. Behav. 25, 577–582.

    Article  CAS  PubMed  Google Scholar 

  63. Abel, E. L. (1971) Effects of marihuana on the solution of anagrams, memory and appetite. Nature 231, 260–261.

    Article  CAS  PubMed  Google Scholar 

  64. Fride, E. (2002) Endocannabinoids in the central nervous system—an overview. Prostaglandins Leukot Essent Fatty Acids 66, 221–233.

    Article  CAS  PubMed  Google Scholar 

  65. Mattes, R. D., Shaw, L. M., and Engelman, K. (1994) Effects of cannabinoids (marijuana) on taste intensity and hedonic ratings and salivary flow of adults. Chem. Senses 19, 125–140.

    Article  CAS  PubMed  Google Scholar 

  66. Bennet, W. and Bennet, S. (1999) Marihuana for AIDS wasting: a critique of the data, in Marihuana and Medicine (Nahas, G., Sutin, K., Harvey, D., and Agurell, S., eds.), Humana Press, Totowa, NJ, pp. 717–721.

    Google Scholar 

  67. Whittle, B., Guy, G., and Robson, P. (2001) Prospects for new cannabis-based prescription drugs. J. Cannabis Therapeut. 1, 183–205.

    Article  CAS  Google Scholar 

  68. Williams, C. M., Rogers, P. J., and Kirkham, T. C. (1998) Hyperphagia in pre-fed rats following oral delta9-THC. Physiol. Behav. 65, 343–346.

    Article  CAS  PubMed  Google Scholar 

  69. Williams, C. M and Kirkham, T. C. (2002) Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol. Behav. 76, 241–250.

    Article  CAS  PubMed  Google Scholar 

  70. De Vry, J., Schreiber, R., Eckel, G., and Jentzsch, K. R. (2004) Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A. Eur. J. Pharmacol. 483, 55–63.

    Article  PubMed  Google Scholar 

  71. Freedland, C. S., Poston, J. S. and Porrino, L. J. (2000) Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol. Biochem. Behav. 67, 265–270.

    Article  CAS  PubMed  Google Scholar 

  72. Williams, C. M. Kirkham, T. C. (2002) Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol. Biochem. Behav. 71, 333–340.

    Article  CAS  PubMed  Google Scholar 

  73. Koch, J. E. and Matthews, S. M.. (2001) Delta9-tetrahydrocannabinol stimulates palatable food intake in Lewis rats: effects of peripheral and central administration. Nutr. Neurosci. 4, 179–187.

    CAS  PubMed  Google Scholar 

  74. Arnone, M., Maruani, J., Chaperon, F., Thiebot, M. H., Poncelet, M., Soubrie, P., and Le Fur, G. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl.) 132, 104–106.

    Article  CAS  Google Scholar 

  75. Colombo, G., Agabio, R., Diaz, G., Lobina, C., Reali, R., and Gessa, G.L. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63, PL113–117.

    Article  CAS  PubMed  Google Scholar 

  76. Hao, S., Avraham, Y., Mechoulam, R., and Berry, E. M. (2000) Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. Eur. J. Pharmacol. 392, 147–156.

    Article  CAS  PubMed  Google Scholar 

  77. Fride, E., Ginzburg, Y., Breuer, A., Bisogno, T., Di Marzo, V., and Mechoulam, R. (2001) Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur. J. Pharmacol. 419, 207–214.

    Article  CAS  PubMed  Google Scholar 

  78. Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., Blau, H., and Mechoulam, R. (2003) Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a “CB3” receptor. Eur. J. Pharmacol. 461, 27–34.

    Article  CAS  PubMed  Google Scholar 

  79. Hofer, M. A. (1996) On the nature and consequences of early loss. Psychosom. Med. 58, 570–581.

    CAS  PubMed  Google Scholar 

  80. Morgan, K. N., Thayer, J. E., and Frye, C. A. (1999) Prenatal stress suppresses rat pup ultrasonic vocalization and myoclonic twitching in response to separation., Dev. Psychobiol. 34, 205–215.

    Article  CAS  PubMed  Google Scholar 

  81. Rodriguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G. F., and Navarro, M. (1996) Corticotropin-releasing factor (CRF) antagonist [DPhe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther. 276, 56–64.

    Google Scholar 

  82. McGregor, I. S., Dastur, F. N., McLellan, R. A., and Brown, R. E. (1996) Cannabinoid modulation of rat pup ultrasonic vocalizations. Eur. J. Pharmacol. 313, 43–49.

    Article  CAS  PubMed  Google Scholar 

  83. Fride, E., Ezra, D., Suris, R., Weisblum, R., Blau, H., and Feigin, C. (2003) Role of CB1 receptors in newborn feeding and survival: maintenance of ultrasonic distress calls and body temperature, Symposium on the Cannabinoids, International Cannabinoids Research Society, Cornwall, Canada, 37.

    Google Scholar 

  84. Fride, E. and Mechoulam, R. (1996b) Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. Brain Res. Dev. Brain Res. 95, 131–134.

    Article  CAS  PubMed  Google Scholar 

  85. Fride E. (2005) Endocannabinoid networds in the central nervous system. In: The Endocannabinoid System in the Brain: From Biology to Therapy, ed. Maccarrone M (editor), in press.

    Google Scholar 

  86. Howlett A. C., Breivogel C. S., Childers, S. R., Deadwyler S. A., Hampson, R. E., Porrino, L. J. (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47Suppl. 1, 345–358.

    Article  CAS  PubMed  Google Scholar 

  87. Freund T. F., Katona I. Piomelli D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017–1066.

    CAS  PubMed  Google Scholar 

  88. Gerdeman G. L., Lovinger D. M. (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. Br. J. Pharmacol. 140, 781–789.

    Article  CAS  PubMed  Google Scholar 

  89. Fride, E. (2004) The endocannabinoid-CB receptor system: importance during development and in pediatric disease. Neuroendocrine Lett. in press.

    Google Scholar 

  90. Fride, E. and Mechoulam, R. (1996) Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology 21, 157–172.

    Article  CAS  PubMed  Google Scholar 

  91. Fride, E., Ezra, D., Suris, R., Weisblum, R., Blau, H., and and Feigin, C. (2003) Role of CB1 receptors in newborn feeding and survival: maintenance of ultrasonic distress calls and body temperature, 2003 Symposium on the Cannabinoids, International Cannabinoids Research Society, Cornwall, Canada, 37.

    Google Scholar 

  92. Fride, E., (2004) Developmental aspects of the endocannabinouid receptor system, in Pharmacology and Physiology of Exogenous and Endogenous Cannabinoids (Wenger, T. ed.) (Research Signpost).

    Google Scholar 

  93. Castellano, C., Rossi-Arnaud, C., Cestari, V., and Costanzi, M. (2003) Cannabinoids and memory: animal studies. Curr. Drug Target-CNS Neurol. Disord. 2, 389–402.

    Article  CAS  Google Scholar 

  94. Varvel, S. A. and Lichtman, A. H. (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J. Pharmacol. Exp. Ther. 301, 915–924.

    Article  CAS  PubMed  Google Scholar 

  95. Wolff, M. C. and Leander J. D. (2003) SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur. J. Pharmacol. 477, 213–217.

    Article  CAS  PubMed  Google Scholar 

  96. Fride, E., Suris, R., Weidenfeld, J., and Mechoulam, R (2004) The endocannabinoid system lowers stress response, 2004 Symposium on the Cannabinoids, ICRS, Paestum, Italy 200.

    Google Scholar 

  97. Hall, F. S., Humby, T., Wilkinson, L. S., and Robbins, T. W. (1997) The effects of isolation-rearing on sucrose consumption in rats. Physiol. Behav. 62, 291–297.

    Article  CAS  PubMed  Google Scholar 

  98. Hall, F. S., Humby, T., Wilkinson, L. S., and Robbins, T. W. (1997) The effects of isolation-rearing of rats on behavioral responses to food and environmental novelty. Physiol. Behav. 62, 281–290.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Behavioral Sciences and Department of Molecular Biology, College of Judea and Samaria, Ariel, Israel

    Ester Fride

  2. Department of Biology, William Paterson University, Wayne, NJ

    Alex Perchuk & Emmanuel S. Onaivi

  3. Molecular Neurobiology Branch, National Institute on Drug Abuse-National Institutes of Health, Baltimore, MD

    F. Scott Hall, George R. Uhl & Emmanuel S. Onaivi

Authors
  1. Ester Fride
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alex Perchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Scott Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George R. Uhl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emmanuel S. Onaivi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biology, William Paterson University, Wayne, NJ

    Emmanuel S. Onaivi PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this protocol

Cite this protocol

Fride, E., Perchuk, A., Hall, F.S., Uhl, G.R., Onaivi, E.S. (2006). Behavioral Methods in Cannabinoid Research. In: Onaivi, E.S. (eds) Marijuana and Cannabinoid Research. Methods In Molecular Medicine™, vol 123. Humana Press. https://doi.org/10.1385/1-59259-999-0:269

Download citation

  • DOI: https://doi.org/10.1385/1-59259-999-0:269

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-350-3

  • Online ISBN: 978-1-59259-999-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation